IA
SRNE

IFP Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

IFP Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-34
Closed -$1K – 4626
2022
Q4 		$1K Sell
34
-50
-60% -$66 ﹤0.01% 4569
2022
Q3 		$2K Buy
84
+34
+68% +$77 ﹤0.01% 4466
2022
Q2 		$1K Hold
50
– – ﹤0.01% 4518
2022
Q1 		$1K Buy
+50
New +$156 ﹤0.01% 4516
2021
Q1 		– Sell
-1,000
Closed -$10.6K – 3288
2020
Q4 		$7K Sell
1,000
-1,102
-52% -$8.85K ﹤0.01% 2217
2020
Q3 		$23K Buy
2,102
+1,102
+110% +$10.1K ﹤0.01% 1598
2020
Q2 		$6K Buy
+1,000
New +$3.83K ﹤0.01% 2039
2019
Q1 		– Sell
-3,725
Closed -$9K – 3635
2018
Q4 		$9K Buy
3,725
+600
+19% +$1.96K ﹤0.01% 2578
2018
Q3 		$14K Sell
3,125
-925
-23% -$5.13K ﹤0.01% 2675
2018
Q2 		$29K Sell
4,050
-2,900
-42% -$19.7K ﹤0.01% 2257
2018
Q1 		$27K Buy
6,950
+1,000
+17% +$7.11K ﹤0.01% 2207
2017
Q4 		$23K Buy
5,950
+2,000
+51% +$5.21K ﹤0.01% 2337
2017
Q3 		$7K Sell
3,950
-400
-9% -$734 ﹤0.01% 3255
2017
Q2 		$9K Buy
4,350
+1,500
+53% +$2.93K ﹤0.01% 3116
2017
Q1 		$11K Sell
2,850
-4,700
-62% -$23.6K ﹤0.01% 2877
2016
Q4 		$37K Hold
7,550
– – ﹤0.01% 2060
2016
Q3 		$58K Buy
7,550
+3,800
+101% +$25.6K ﹤0.01% 1720
2016
Q2 		$21K Buy
+3,750
New +$24K ﹤0.01% 2321
2016
Q1 		– Sell
-4,950
Closed -$43K – 3625
2015
Q4 		$43K Buy
+4,950
New +$41.8K ﹤0.01% 1711

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

IFP Advisors's SRNE Position: Q1 2023 in Review

IFP Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 34 shares — an estimated $1K sold.

IFP Advisors first reported a position in SRNE in Q4 2015 and held it in 19 quarters. The position peaked at $58K in Q3 2016. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • IFP Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • IFP Advisors sold 34 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $1K.
  • IFP Advisors first reported a position in Sorrento Therapeutics, Inc. in Q4 2015 and held it in 19 quarters.
  • IFP Advisors's Sorrento Therapeutics, Inc. position peaked at $58K in Q3 2016.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.